Rheumatology

Seattle Genetics Presents on SGN-70 at American College of Rheumatology Meeting

Seattle Genetics, Inc. (Nasdaq: SGEN) today presented preclinical data on SGN-70 at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco, California. SGN-70 is a humanized monoclonal antibody...

University Of Kentucky Launches Clinical Outcomes-Based Educational Initiative To Reinforce...

The University of Kentucky Pharmacy and Medicine Continuing Education Office (UKPMCE) announced today the launch of the Rheumatoid Arthritis Educational Challenge (RAEC), which will address deficits in the treatment of...

Data Demonstrate ORENCIA(R) (abatacept) Improves Health-Related Quality Of Life, Pain And Sleep...

Bristol-Myers Squibb Company (NYSE: BMY) today announced at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco results from a 10-month study which showed that ORENCIA® (abatacept), compared to...

Clinical Remission Figures Double For People With Rheumatoid Arthritis Following Multiple Courses...

Results of the REFLEX study1 show that the number of people with rheumatoid arthritis (RA) achieving clinical remission from their disease doubled over three successive treatment courses with MabThera (rituximab) when used in...

CIMZIA(R) (Certolizumab Pegol) Provides Rapid And Sustained Relief From Signs And Symptoms Of...

UCB announced results from several Phase III clinical trials evaluating CIMZIA(R) (certolizumab pegol) - the only PEGylated anti-TNF (Tumor Necrosis Factor) - presented at the American College of Rheumatology (ACR) Annual...

One-Year Data Show Golimumab Improved Signs And Symptoms In Patients With Psoriatic Arthritis In...

More than half of patients receiving every four week subcutaneous injections of golimumab (CNTO 148) 50 mg and 100 mg, an investigational therapy, experienced sustained improvements in the joint and skin symptoms of active...

Seattle Genetics Presents on SGN-70 at American College of Rheumatology Meeting (Business Wire)

BOTHELL, Wash.----Seattle Genetics, Inc. today presented preclinical data on SGN-70 at the American College of Rheumatology Annual Scientific Meeting in San Francisco, California. SGN-70 is a humanized monoclonal antibody...

Active Biotech Presents New Data regarding the 57-57 SLE Project at American College of...

LUND, SWEDEN--(Marketwire - October 28, 2008) - Active Biotech (NASDAQ OMX Nordic: ACTI) has presented data regarding the 57-57 project at the American College of Rheumatology (ACR) Annual Scientific Meeting, a premier event...

Data Demonstrate ORENCIA® (abatacept) Improves Health-Related Quality of Life, Pain and Sleep...

SAN FRANCISCO, October 27, 2008 - Bristol-Myers Squibb Company (NYSE: BMY) today announced at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco results from a 10-month study which showed that...

Data Demonstrate ORENCIA(R) (abatacept) Improves Health-Related Quality of Life, Pain and Sleep Qu..

Bristol-Myers Squibb Company (NYSE: BMY) today announced at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco results from a 10-month study which showed that ORENCIA® (abatacept), compared to...